Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04266860 · ClinicalTrials.gov registry record · NA
Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients
A NA study of Lupus Nephritis and Lupus Erythematosus, Systemic, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT04266860: Completed NA study of Lupus Nephritis and Lupus Erythematosus, Systemic, sponsored by Qure Healthcare.
NCT04266860 is a NA study of Lupus Nephritis and Lupus Erythematosus, Systemic that has completed, run by Qure Healthcare. The registered enrollment target is 166 participants, below the 305-participant average among 30 other Lupus Nephritis trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04266860, a NA study of Lupus Nephritis and Lupus Erythematosus, Systemic, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will collect high-quality randomized controlled data from a nationally representative sample of practicing rheumatologists to determine how they currently manage patients with SLE (systemic lupus erythematosus) and how the results of DxTerity's IFN-1 (interferon type I) test change clinical decision making.
Primary Outcome
Doctors receive scores on their simulated cases, or CPVs, based upon their quality of care. This measure will assess the pre- vs post-difference in the overall and the diagnostic and treatment quality scores between control physicians using standard of care diagnostic tools and intervention physicians with access to DxTerity test results, including by use case types.
Conditions Studied
Interventions
- OTHER Experimental - Test Results and Education
Study Locations (1)
California
- QURE Healthcare - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2012-03-01 |
| Est. Completion | 2013-03-01 |
| Phase | NA |
What the finished NCT04266860 record still lists
NCT04266860 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 305-participant average among 30 other Lupus Nephritis trials with a reported enrollment target (46% lower).
The record links to 2 conditions, with Lupus Nephritis appearing as the primary indexed condition, and to 1 intervention - of which Experimental - Test Results and Education is the first listed.
NCT04266860 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04266860 about?
NCT04266860 is a clinical study titled "Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients". This study will collect high-quality randomized controlled data from a nationally representative sample of practicing rheumatologists to determine how they currently manage patients with SLE (systemic lupus erythematosus) and how the results of DxTerity's IFN-1 (interferon type I) test change clinic...
What is the current status of trial NCT04266860?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2012-03-01. Estimated completion is 2013-03-01.
What conditions does trial NCT04266860 study?
This clinical trial studies the following conditions: Lupus Nephritis, Lupus Erythematosus, Systemic.
What interventions are being tested in trial NCT04266860?
The interventions under investigation include: Experimental - Test Results and Education (OTHER).
Who is sponsoring clinical trial NCT04266860?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04266860 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lupus Nephritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04266860's enrollment target sits among peer trials
166 11th of 30 higher than 20 of 30 other Lupus Nephritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lupus Nephritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
RECRUITING · Phase 2
-
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
RECRUITING · Phase 2
-
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
RECRUITING · Phase 3
-
VIBRANT: VIB4920 for Active Lupus Nephritis
RECRUITING · Phase 2
-
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RECRUITING · Phase 1
-
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI